Biotechnology company 4basebio PLC (AIM: 4BB) announced on Monday that a global Tier 1 pharmaceutical partner has commenced dosing patients in a US Phase I/II clinical trial using ...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
27 October 2025 -
27 October 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Monday that the US Food and Drug Administration (FDA) has approved an updated indication for Winrevair (sotatercept-csrk) ...
27 October 2025 - Investment fund RTW Biotech Opportunities Ltd (LSE: RTW) reported on Monday that its portfolio company Avidity Biosciences Inc (Nasdaq: RNA) has agreed to be acquired by Novartis AG (SWX: NOVN) for USD72 per share in cash, valuing t...
27 October 2025 - Nanoform Finland Plc (Nasdaq First North Growth Market: NANOFH, NANOFS), a medicine performance-enhancing company, on Monday announced a partnership with specialty pharma company Revio Therapeutics to co-develop and commercialise GL...
27 October 2025 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Monday that Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for Leqembi (lecane...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe